Report for: Dual thrombolytic therapy with mutant pro-urokinase and small bolus alteplase for ischemic stroke (DUMAS): study protocol for a multicenter randomized controlled phase II trial

Title	Dual thrombolytic therapy with mutant pro-urokinase and small bolus alteplase for ischemic stroke (DUMAS): study protocol for a multicenter randomized controlled phase II trial
Published in	Trials, August 2022
DOI	10.1186/s13063-022-06596-z
Pubmed ID	35945566
Authors	Nadinda A. M. van der Ende, Bob Roozenbeek, Lucas E. M. Smagge, Sven P. R. Luijten, Leo A. M. Aerden, Petra Kraayeveld, Ido R. van den Wijngaard, Geert J. Lycklama à Nijeholt, Heleen M. den Hertog, H. Zwenneke Flach, Alexis C. Wallace, Victor Gurewich, Gregory J. del Zoppo, William J. Meurer, Hester F. Lingsma, Aad van der Lugt, Diederik W. J. Dippel

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.

Country	Count	As %
United States	1	50%
Unknown	1	50%

Type	Count	As %
Members of the public	2	100%

Mendeley readers

The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Country	Count	As %
Unknown	16	100%

Readers by professional status	Count	As %
Professor > Associate Professor	2	13%
Other	1	6%
Student > Doctoral Student	1	6%
Student > Ph. D. Student	1	6%
Student > Bachelor	1	6%
Other	2	13%
Unknown	8	50%

Readers by discipline	Count	As %
Neuroscience	3	19%
Medicine and Dentistry	2	13%
Business, Management and Accounting	1	6%
Biochemistry, Genetics and Molecular Biology	1	6%
Unknown	9	56%

Dual thrombolytic therapy with mutant pro-urokinase and small bolus alteplase for ischemic stroke (DUMAS): study protocol for a multicenter randomized controlled phase II trial